Dramatic improvement of DC-based immunotherapy against various malignancies

Frontiers in Bioscience

Volumn 16, Issue 6, 2011, Pages 2233-2242

  Harada, Yui ^a,b   Yonemitsu, Yoshikazu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Activation; Cancer; Dendritic cell; Expansion; Immunotherapy; Review; SeV vector

Indexed keywords

HUMAN PARAINFLUENZA VIRUS 1; SENDAI VIRUS;

CANCER VACCINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; DENDRITIC CELL; DOSE RESPONSE; EXPERIMENTAL MELANOMA; HUMAN; IMMUNOLOGY; METHODOLOGY; MOUSE; NEOPLASM;

ANIMALS; CANCER VACCINES; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MELANOMA, EXPERIMENTAL; MICE; MODELS, IMMUNOLOGICAL; NEOPLASMS;

EID: 79959741428     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3850     Document Type: Article

References (53)

1. R.M. Steinman, J.C. Adams, and Z.A. Cohn: Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J Exp Med 141, 804-820 (1975)
2. R.M. Steinman and Z.A. Cohn: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137, 1142-1162 (1973)
3. R.M. Steinman and Z.A. Cohn: Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med 139, 380-397 (1974)
4. H. Iwasaki and K. Akashi: Myeloid lineage commitment from the hematopoietic stem cell. Immunity 26, 726-740 (2007) (Pubitemid 46907674)
5. N. Onai, A. Obata-Onai, M.A. Schmid, T. Ohteki, D. Jarrossay, and M.G. Manz: Identification of clonogenic common Flt3+ M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol 8, 1207-1216 (2007) (Pubitemid 350011759)
6. C. Waskow, K. Liu, G. Darrasse-Jèze, P. Guermonprez, F. Ginhoux, M. Merad, T. Shengelia, K. Yao, and M. Nussenzweig: The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol 9, 676-683 (2008) (Pubitemid 351712638)
7. L. Conti and S. Gessani: GM-CSF in the generation of dendritic cells from human blood monocyte precursors: Recent advances. Immunobiology 213, 859-870 (2008)
8. S. Akira, S. Uematsu, and O. Takeuchi: Pathogen recognition and innate immunity. Cell 124, 783-801 (2006) (Pubitemid 43261452)
9. J. Banchereau and A.K. Palucka: Dendritic cells as therapeutic vaccines against cancers. Nat Rev Immunol 5, 296-306 (2005) (Pubitemid 40516155)
10. S.P. Schoenberger, R.E. Toes, E.I. van der Voort, R. Offringa, and C.J. Melief: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40 L interactions. Nature 393, 413-414 (1998)
11. L.E. Harrington, R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy, and C.T. Weaver: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6, 1123-1132 (2005) (Pubitemid 41541790)
12. L. Steinman: A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13, 139-145 (2007)
13. C. Rieser, G. Böck, H. Klocker, G. Bartsch, and M. Thurnher: Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of Interleukin 12 production. J Exp Med 186, 1603-1608 (1997) (Pubitemid 27479821)
14. P. Kaliński, P.L. Vieira, J.H. Schuitemaker, E.C. de Jong, and M.L. Kapsenberg: Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97, 3466-3469 (2001)
15. C. Yao, D. Sakata, Y. Esaki, Y. Li, T. Matsuoka, K. Kuroiwa, Y. Sugimoto, and S. Narumiya: Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion. Nat Med 2009 15, 633-640 (2009)
16. M. F. Lipscomb and B.J. Masten: Dendritic cells: Immune regulators in health and disease. Physiol Rev 82, 97-130 (2002) (Pubitemid 34654216)
17. R. Cerio, C.E. Griffiths, K.D. Cooper, B.J. Nickoloff, and J.T. Headington: Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 121, 421-431 (1989) (Pubitemid 19251469)
18. C. Caux, B. Vanbervliet, C. Massacrier, C. Dezutter- Dambuyant, B. de Saint-Vis, C. Jacquet, K. Yoneda, S. Imamura, D. Schmitt, and J. Banchereau: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 184, 695-706 (1996) (Pubitemid 26324123)
19. N. Romani, S. Gruner, D. Brang, E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P.O. Fritsch, R.M. Steinman, and G. Schuler: Proliferating dendritic cell progenitors in human blood. J Exp Med 180, 83-93 (1994) (Pubitemid 24181058)
20. C. Caux, C. Massacrier, B. Dubois, J. Valladeau, C. Dezutter-Dambuyant, I. Durand, D. Schmitt, and S. Saeland: Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non- Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol 66, 781-791 (1999) (Pubitemid 29532040)
21. F. Sallusto and A. Lanzavecchia: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179, 1109-1118 (1994)
22. T. Ito, M. Inaba, K. Inaba, J. Toki, S. Sogo, T. Iguchi, Y. Adachi, K. Yamaguchi, R. Amakawa, J. Valladeau, S. Saeland, S. Fukuhara, and S. Ikehara: A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 163, 1409-1419 (1999) (Pubitemid 29352761)
23. L.J. Zhou and T.F. Tedder: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U.S.A. 93, 2588-2592 (1996) (Pubitemid 26104391)
24. M. Cella, D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5, 919-923 (1999) (Pubitemid 29372419)
25. G. Grouard, M.C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y.J. Liu: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185, 1101-1111 (1997) (Pubitemid 27136802)
26. N. Kohrgruber, N. Halanek, M. Gröger, D. Winter, K. Rappersberger, M. Schmitt-Egenolf, G. Stingl, and D. Maurer: Survival, maturation, and function of CD11c2 and CD11c1 peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 163, 3250-3259 (1999) (Pubitemid 29431826)
27. F.P. Siegal, N. Kadowaki, M. Shodell, P.A. Fitzgerald- Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y.J. Liu: The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999)
28. M.A. Cheever, J.P. Allison, A.S. Ferris, O.J. Finn, B.M. Hastings, T.T. Hecht, I. Mellman, S.A. Prindiville, J.L. Viner, L.M. Weiner, and L.M. Matrisian: The prioritization of cancer antigens: A National Cancer Institute pilot project for the acceleration of translational research. Clin Cancer Res 15, 5323-5337 (2009)
29. A. Komaru, Y. Ueda, A. Furuya, S. Tanaka, K. Yoshida, T. Kato, H. Kinoh, Y. Harada, H. Suzuki, M. Inoue, M. Hasegawa, T. Ichikawa, and Y. Yonemitsu: Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus. J Immunol 183, 4211-4219 (2009)
30. J.I. Mayordomo, T. Zorina, W.J. Storkus, L. Zitvogel, C. Celluzzi, L.D. Falo, C.J. Melief, S.T. Ildstad, W.M. Kast, A.B. Deleo AB, and M.T. Lotze: Bone marrowderived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1, 1297-302 (1995)
31. F.J. Hsu, C. Benike, F. Fagnoni, T.M. Liles, D. Czerwinski, B. Taidi, E.G. Engleman, and R. Levy: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1, 52-58 (1996) (Pubitemid 26028073)
32. F.O. Nestle, S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 3, 328-332 (1998) (Pubitemid 28144092)
33. S.A. Rosenberg, J.C. Yang, and N.P. Restifo: Cancer immunotherapy: moving beyond current vaccines. Nat Med 9, 909-915 (2004) (Pubitemid 39273730)
34. F.O. Nestle, A. Farkas, and C. Conrad: Dendritic-cellbased therapeutic vaccination against cancer. Curr Opin Immunol 17, 163-169 (2005) (Pubitemid 40343103)
35. C.G. Figdor, I.J. de Vries, W.J. Lesterhuis, and C.J. Melief: Dendritic cell immunotherapy: mapping the way. Nat Med 10, 475-480 (2004) (Pubitemid 38667904)
36. A. Langenkamp, M. Messi, A. Lanzavecchia, and F. Sallusto: Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 1, 311-316 (2000)
37. S. Hugues, L. Fetler, L. Bonifaz, J. Helft, F. Amblard, and S. Amigorena: Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol 2004, 5, 1235-1242 (2004) (Pubitemid 41057738)
38. Y. Nagai: Paramyxovirus replication and pathogenesis: reverse genetics transforms understanding. Rev Med Virol 9, 83-99 (1999) (Pubitemid 29245740)
39. M.A. Markwell, L. Svennerholm, and J.C. Paulson: Specific gangliosides function as host cell receptors for Sendai virus. Proc Natl Acad Sci U.S.A. 78, 5406-5410 (1981) (Pubitemid 12248595)
40. Y. Yonemitsu, C. Kitson, S. Ferrari, R. Farley, U. Griesenbach, D. Judd, R. Steel, P. Scheid, J. Zhu, P.K. Jeffery, A. Kato, M.K. Hasan, Y. Nagai, I. Masaki, M. Fukumura, M. Hasegawa, D.M. Geddes, and E.W. Alton: Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol 18, 970-973 (2000) (Pubitemid 32977378)
41. D.E. Speiser, R. Miranda, A. Zakarian, M.F. Bachmann, K. McKall-Faienza, B. Odermatt, D. Hanahan, R.M. Zinkernagel, and P.S. Ohashi: Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J Exp Med 186, 645-653 (1997) (Pubitemid 27381529)
42. S. Shibata, S. Okano, Y. Yonemitsu, M. Onimaru, S. Sata, H. Nagata-Takeshita, M. Inoue, T. Zhu, M. Hasegawa, Y. Moroi, M. Furue, and K. Sueishi: Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai Virus and its modulation by exogenous IFN-beta gene. J Immunol 177, 3564-3576 (2006) (Pubitemid 44359887)
43. J. Sirén, T. Sareneva, J. Pirhonen, M. Strengell, V. Veckman, I. Julkunen, and S. Matikainen: Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages. J Gen Virol 85, 2357-2364 (2004) (Pubitemid 39162608)
44. H. Achdout, T.I. Arnon, G. Markel, T. Gonen-Gross, G. Katz, N. Lieberman, R. Gazit, A. Joseph, E. Kedar, and O. Mandelboim: Enhanced recognition of human NK receptors after influenza virus infection. J Immunol 171, 915-923 (2003) (Pubitemid 36871405)
45. O. Mandelboim, N. Lieberman, M. Lev, L. Paul, T.I. Arnon, Y. Bushkin Y, D.M. Davis, J.L. Strominger, J.W. Yewdell, and A. Porgador: Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060 (2001) (Pubitemid 32204059)
46. E. Bell: NK cells need a license to kill. Nat Rev Immunol 5, 674 (2005)
47. Parham P: Taking license with natural killer cell maturation and repertoire development. Immunol Rev 214, 155-160 (2006) (Pubitemid 44707909)
48. E.F. Castillo, S.W. Stonier, L. Frasca, and K.S. Schluns: Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation. J Immunol 183, 4948-4956 (2009)
49. N.D. Huntington, N. Legrand, N.L. Alves, B. Jaron, K. Weijer, A. Plet, E. Corcuff, E. Mortier, Y. Jacques, H. Spits, and J.P. Di Santo: IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206, 25-34 (2009)
50. M. B. Lodoen and L. L. Lanier: Viral modulation of NK cell immunity. Nat Rev Microbiol 3, 59-69 (2005) (Pubitemid 40028469)
51. K. Tatsuta, S. Tanaka, T. Tajiri, S. Shibata, A. Komaru, Y. Ueda, M. Inoue, M. Hasegawa, S. Suita, K. Sueishi, T. Taguchi, and Y. Yonemitsu: Complete elimination of established neuroblastoma by synergistic action of gammairradiation and DCs treated with rSeV expressing interferon-beta gene. Gene Ther 16, 240-251 (2009)
52. RIG-I helicase-independent pathway in sendai virusactivated dendritic cells is critical for preventing lung metastasis of AT6.3 pProstate cancer. Neoplasia 12, 906-914 (2010)
53. Y. Harada, Y. Ueda, H. Kinoh, A. Komaru, T. Fuji- Ogawa, A. Furuya, A. Iida, M. Hasegawa, T. Ichikawa, and Y. Yonemitsu: Cytokine-based log-scale expansion of functional murine dendritic cells. PLos One 4, e6674 (2009)